| Date |
Report No. |
Title |
| Date Sept. 30, 2010 |
Report No. GAO-10-961 |
Title
United States Government Accountability Office GAO
September 2010 Report to the Committee on Oversight and Government Reform, House of Representatives DRUG SAFETY FDA Has Conducted More Foreign Inspections and Begun to Improve Its Information on Foreign Establishments, but More Progress Is Needed GAO-10-961 September 2010 DRUG SAFETY
Accountability • Integrity • Reliability FDA Has Conducted M... |
| Date Sept. 30, 2008 |
Report No. GAO-08-1074R |
Title
United States Government Accountability Office Washington, DC 20548 September 30, 2008 The Honorable Henry A. Waxman Chairman Committee on Oversight and Government Reform House of Representatives Subject: Medicare Part D Prescription Drug Coverage: Federal Oversight of Reported Price Concessions Data Dear Mr. Chairman: To help Medicare beneficiaries manage the rising cost of prescription drugs, Co... |
| Date Sept. 22, 2008 |
Report No. GAO-08-970 |
Title
United States Government Accountability Office GAO
September 2008 Report to Congressional Requesters DRUG SAFETY Better Data Management and More Inspections Are Needed to Strengthen FDA’s Foreign Drug Inspection Program GAO-08-970 September 2008 DRUG SAFETY Highlights
Highlights of GAO-08-970, a report to congressional requesters Accountability Integrity Reliability Better Data Management and Mo... |
| Date July 30, 2008 |
Report No. GAO-08-415 |
Title
United States Government Accountability Office GAO
July 2008 Report to the Chairman, Committee on Agriculture, Nutrition, and Forestry, U.S. Senate FOOD STAMP PROGRAM Options for Delivering Financial Incentives to Participants for Purchasing Targeted Foods GAO-08-415 July 2008 FOOD STAMP PROGRAM Highlights
Highlights of GAO-08-415, a report to the Chairman, Committee on Agriculture, Nutrition, and... |
| Date July 28, 2008 |
Report No. GAO-08-835 |
Title
United States Government Accountability Office GAO
July 2008 Report to the Ranking Member, Committee on Finance, U.S. Senate PRESCRIPTION DRUGS FDA’s Oversight of the Promotion of Drugs for Off-Label Uses GAO-08-835 July 2008 PRESCRIPTION DRUGS Highlights
Highlights of GAO-08-835, a report to the Ranking Member, Committee on Finance, U.S. Senate Accountability Integrity Reliability FDA’s Overs... |
| Date May 8, 2008 |
Report No. GAO-08-758T |
Title
United States Government Accountability Office GAO
For Release on Delivery Expected at 10:00 a.m. EDT Thursday, May 8, 2008 Testimony Before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives PRESCRIPTION DRUGS Trends in FDA’s Oversight of Direct-to-Consumer Advertising
Statement of Marcia Crosse Director, Health Care GAO-08-758T May 8, 2... |
| Date April 17, 2008 |
Report No. GAO-08-686T |
Title
United States Government Accountability Office GAO
For Release on Delivery Expected at 1:00 p.m. EDT Thursday, April 17, 2008 Testimony Before the Subcommittee on Domestic Policy, Committee on Oversight and Government Reform, House of Representatives HUMANE METHODS OF HANDLING AND SLAUGHTER Public Reporting on Violations Can Identify Enforcement Challenges and Enhance Transparency
Statement of Lis... |
| Date June 26, 2007 |
Report No. GAO-07-1050T |
Title
United States Government Accountability Office GAO
For Release on Delivery Expected at 10:00 a.m. EDT Tuesday, June 26, 2007 Testimony Before the Subcommittee on Health, Committee on Ways and Means, House of Representatives END-STAGE RENAL DISEASE Medicare Should Pay a Bundled Rate for All ESRD Items and Services
Statement for the Record of A. Bruce Steinwald Director, Health Care GAO-07-1050T Mr.... |
| Date May 22, 2007 |
Report No. GAO-07-898T |
Title
United States Government Accountability Office GAO
For Release on Delivery Expected at 10:00 a.m. EDT Tuesday, May 22, 2007 Testimony Before the Subcommittee on Health, Committee on Energy and Commerce, House of Representatives PEDIATRIC DRUG RESEARCH The Study and Labeling of Drugs for Pediatric Use under the Best Pharmaceuticals for Children Act
Statement of Marcia Crosse Director, Health Care G... |
| Date March 22, 2007 |
Report No. GAO-07-557 |
Title
United States Government Accountability Office GAO
March 2007 Report to Congressional Committees PEDIATRIC DRUG RESEARCH Studies Conducted under Best Pharmaceuticals for Children Act GAO-07-557 March 2007 PEDIATRIC DRUG RESEARCH Highlights
Highlights of GAO-07-557, a report to congressional committees Accountability Integrity Reliability Studies Conducted under Best Pharmaceuticals for Children Ac... |
| Date Feb. 8, 2007 |
Report No. GAO-07-449T |
Title
United States Government Accountability Office GAO
For Release on Delivery Expected at 1:00 p.m. EST Thursday, February 8, 2007 Testimony Before the Subcommittee on Agriculture, Rural Development, FDA, and Related Agencies, Committee on Appropriations, House of Representatives FEDERAL OVERSIGHT OF FOOD SAFETY High-Risk Designation Can Bring Needed Attention to Fragmented System
Statement of David ... |
| Date Dec. 6, 2006 |
Report No. GAO-07-266T |
Title
United States Government Accountability Office GAO
For Release on Delivery Expected at 10:30 a.m. EST Wednesday, December 6, 2006 Testimony Before the Committee on Ways and Means, House of Representatives END-STAGE RENAL DISEASE Medicare Payments for All ESRD Services, Including Injectable Drugs, Should Be Bundled
Statement of David M. Walker Comptroller General of the United States GAO-07-266T Mr... |
| Date Nov. 13, 2006 |
Report No. GAO-07-77 |
Title
United States Government Accountability Office GAO
November 2006 Report to the Chairman, Committee on Ways and Means, House of Representatives END-STAGE RENAL DISEASE Bundling Medicare’s Payment for Drugs with Payment for All ESRD Services Would Promote Efficiency and Clinical Flexibility GAO-07-77 November 2006 END-STAGE RENAL DISEASE Highlights
Highlights of GAO-07-77, a report to the Chairman... |
| Date May 17, 2005 |
Report No. GAO-05-549T |
Title
United States Government Accountability Office GAO
For Release on Delivery Expected at 2:00 p.m. EDT Tuesday, May 17, 2005 Testimony Before the Subcommittee on the Federal Workforce and Agency Organization, Committee on Government Reform, House of Representatives OVERSEEING THE U.S. FOOD SUPPLY Steps Should be Taken to Reduce Overlapping Inspections and Related Activities
Statement of Robert A. Ro... |
| Date March 30, 2005 |
Report No. GAO-05-213 |
Title
United States Government Accountability Office GAO
March 2005 Report to Congressional Requesters OVERSIGHT OF FOOD SAFETY ACTIVITIES Federal Agencies Should Pursue Opportunities to Reduce Overlap and Better Leverage Resources GAO-05-213 a March 2005 Highlights
Highlights of GAO-05-213, a report to congressional requesters Accountability Integrity Reliability OVERSIGHT OF FOOD SAFETY ACTIVITIES Fed... |
| Date July 22, 2004 |
Report No. GAO-04-839T |
Title
United States Government Accountability Office GAO
For Release on Delivery Expected at 9:00 a.m. EDT Thursday, July 22, 2004 Testimony Before the Permanent Subcommittee on Investigations, Committee on Governmental Affairs, U.S. Senate PRESCRIPTION DRUGS Preliminary Observations on Efforts to Enforce the Prohibitions on Personal Importation
Statement of Richard M. Stana, Director Homeland Security ... |
| Date Jan. 30, 2004 |
Report No. GAO-04-247 |
Title
United States General Accounting Office GAO
January 2004 Report to Congressional Requesters HUMANE METHODS OF SLAUGHTER ACT USDA Has Addressed Some Problems but Still Faces Enforcement Challenges GAO-04-247 January 2004 HUMANE METHODS OF SLAUGHTER ACT USDA Has Addressed Some Problems but Still Faces Enforcement Challenges Highlights of GAO-04-247, a report to Congressional Requesters In 1978, the ... |
| Date Oct. 23, 2003 |
Report No. GAO-04-195T |
Title
United States General Accounting Office GAO
For Release on Delivery Expected at 10:00 a.m. Thursday, October 23, 2003 Testimony Before the Committee on Health, Education, Labor, and Pensions, U.S. Senate PRESCRIPTION DRUGS State and Federal Oversight of Drug Compounding by Pharmacies
Statement of Janet Heinrich Director, Health Care—Public Health Issues GAO-04-195T October 23, 2003 PRESCRIPTION ... |
| Date Aug. 5, 2003 |
Report No. GAO-03-781SP |
Title
|
| Date July 23, 2003 |
Report No. GAO-03-1042T |
Title
United States General Accounting Office GAO
For Release on Delivery Expected at 10:00 a.m. Wednesday, July 23, 2003 Testimony Before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives DIETARY SUPPLEMENTS CONTAINING EPHEDRA Health Risks and FDA’s Oversight
Statement of Marcia Crosse Acting Director, Health Care—Public Health and Science ... |
| Date Dec. 17, 2001 |
Report No. GAO-02-59 |
Title
United States General Accounting Office GAO
December 2001 Report to the Committee on Agriculture, Nutrition, and Forestry, U.S. Senate FOOD SAFETY Weaknesses in Meat and Poultry Inspection Pilot Should Be Addressed Before Implementation GAO-02-59 Contents Letter
Results in Brief Background Pilot Project Makes Industry More Responsible and Accountable for Product Safety and Quality, While Continuin... |
| Date Sept. 14, 2001 |
Report No. GAO-01-1011 |
Title
United States General Accounting Office GAO
September 2001 Report to Congressional Requesters ATTENTION DISORDER DRUGS Few Incidents of Diversion or Abuse Identified by Schools GAO-01-1011 Contents Letter
Results in Brief Background Few Incidents of Diversion or Abuse of Attention Disorder Drugs Identified by Schools Most Schools Dispense Attention Disorder Medications and Follow Drug Security Pro... |
| Date Sept. 11, 2000 |
Report No. HEHS-00-175 |
Title
United States General Accounting Office GAO
September 2000 Report to Congressional Requesters CHILDREN AND PESTICIDES New Approach to Considering Risk Is Partly in Place GAO/HEHS-00-175 Contents Letter Appendixes
Appendix I: Methodology 3 24 26 34 Appendix II: Three Pesticides Evaluated Under FQPA’s New Requirements: Dicofol, Methomyl, and Phosmet Appendix III: GAO Contact and Staff Acknowledgme... |
| Date July 11, 2000 |
Report No. RCED-00-156 |
Title
United States General Accounting Office GAO
July 2000 Report to Congressional Committees FOOD SAFETY Improvements Needed in Overseeing the Safety of Dietary Supplements and “Functional Foods” GAO/RCED-00-156 Contents Letter Appendixes
Appendix I: Agencies and Organizations Contacted 3 34 36 43 Appendix II: Comments From the Food and Drug Administration Appendix III: GAO Contacts and Staff Ackn... |
| Date Feb. 25, 2000 |
Report No. RCED-00-65 |
Title
United States General Accounting Office GAO
February 2000 Report to Congressional Requesters FOOD SAFETY FDA’s Use of Faster Tests to Assess the Safety of Imported Foods GAO/RCED-00-65 United States General Accounting Office Washington, D.C. 20548 Resources, Community, and Economic Development Division B-284437 February 25, 2000 The Honorable Tom Bliley Chairman, Committee on Commerce House of R... |
| Date May 26, 1999 |
Report No. T-RCED-99-200 |
Title
United States General Accounting Office GAO
To be Released at 9 a.m. EDT Wednesday May 26, 1999 Testimony
Before the Committee on Agriculture, Nutrition, and Forestry, U.S. Senate FRESH PRODUCE Potential Implications of Country-of-Origin Labeling
Statement for the Record by Robert E. Robertson, Associate Director, Food and Agriculture Issues, Resources, Community, and Economic Development Division... |
| Date April 28, 1999 |
Report No. T-RCED-99-172 |
Title
United States General Accounting Office GAO
For Release on Delivery Expected at 10 a.m. EDT Wednesday April 28, 1999 Testimony
Before the Subcommittee on Livestock and Horticulture, Committee on Agriculture, House of Representatives FRESH PRODUCE Potential Conseqences of Country-of-Origin Labeling
Statement of Robert E. Robertson, Associate Director, Food and Agriculture Issues, Resources, Communi... |
| Date April 21, 1999 |
Report No. RCED-99-112 |
Title
United States General Accounting Office GAO
April 1999 Report to Congressional Committees FRESH PRODUCE Potential Consequences of Country-of-Origin Labeling GAO/RCED-99-112 GAO United States General Accounting Office Washington, D.C. 20548 Resources, Community, and Economic Development Division B-282173 April 21, 1999 The Honorable Thad Cochran Chairman The Honorable Herb Kohl Ranking Minority Mem... |
| Date June 3, 1997 |
Report No. HEHS-97-146R |
Title
GAO United States General Accounting Office Washington, D.C. 20648 Health, Education and Human Services Division B-277157 June 3, 1997 The Honorable James M. Jeffords Chairman The Honorable Edward M. Kennedy Ranking Minority Member Committee on Labor and Human Resources United States Senate Subject: Medical Devices: FDA Review Times. 1989 Through 1996 The Food and Drug Administration (FDA) regulat... |
| Date Jan. 29, 1997 |
Report No. HEHS-97-21 |
Title
United States General Accounting Office GAO
January 1997 Report to Congressional Committees MEDICAL DEVICE REPORTING Improvements Needed in FDA’s System for Monitoring Problems With Approved Devices GAO/HEHS-97-21 GAO United States General Accounting Office Washington, D.C. 20548 Health, Education, and Human Services Division B-266228 January 29, 1997 The Honorable James M. Jeffords Chairman The... |
| Date Sept. 12, 1996 |
Report No. T-HEHS-96-212 |
Title
United States General Accounting Office GAO
For Release on Delivery Expected at 10:00 a.m. September 12, 1996 Testimony
Before the Subcommittee on Human Resources and Intergovernmental Relations, Committee on Government Reform and Oversight, U. S. House of Representatives PRESCRIPTION DRUGS Implications of Drug Labeling and Off-Label Use
Statement of Sarah F. Jagger Director of Health Services Qua... |
| Date May 2, 1996 |
Report No. T-PEMD-96-9 |
Title
United States General Accounting Office GAO
For Release on Delivery Expected at 10:00 a.m. EST Thursday May 2, 1996 Testimony
Before the Subcommittee on Health and Environment, Committee on Commerce, House of Representatives FDA REVIEW TIMES Statement of Mary R. Hamilton, Ph.D. Director of Program Evaluation in Human Services Areas Program Evaluation and Methodology Division G A O years
1921 - 199... |
| Date April 5, 1996 |
Report No. HEHS-96-71 |
Title
United States General Accounting Office GAO
April 1996 Report to the Chairman, Committee on Labor and Human Resources, U.S. Senate EUROPEAN UNION DRUG APPROVAL Overview of New European Medicines Evaluation Agency and Approval Process G A O years
1921 - 1996 GAO/HEHS-96-71 GAO United States General Accounting Office Washington, D.C. 20548 Health, Education, and Human Services Division B-261605 Apri... |
| Date March 19, 1996 |
Report No. HEHS-96-30 |
Title
United States General Accounting Office GAO
March 1996 Report to Congressional Requesters FDA LABORATORIES Magnitude of Benefits Associated With Consolidation Is Questionable G A O years
1921 - 1996 GAO/HEHS-96-30 GAO United States General Accounting Office Washington, D.C. 20548 Health, Education, and Human Services Division B-270022 March 19, 1996 The Honorable Paul Sarbanes United States Senate... |
| Date Feb. 21, 1996 |
Report No. T-PEMD-96-6 |
Title
United States General Accounting Office Testimony
Before the Committee on Labor and Human Resources U.S. Senate For Release on Delivery Expected at 9~30a.m. EST Wednesday February 2 1,1996 Statement of Mary R. Hamilton, Ph.D. Director of Program Evaluation in the Human Services Area Program Evaluation and Methodology Division GAOfI’ -PEMD-96-6 Dear Madam Chairman: In October 1995, GAO issued a r... |
| Date Dec. 21, 1995 |
Report No. HEHS-96-60R |
Title
GAO United States General Accounting Office Washington, D.C. 20548 Health, Education and Human Services Division B-266229 December 21, 1995 The Honorable Nancy Landon Kassebaum Chairman, Committee on Labor and Human Resources United States Senate Dear Madam Chairman: Under current law, U.S. pharmaceutical manufacturers must obtain approval from the Food and Drug Administration (FDA) to export drug... |
| Date Dec. 8, 1995 |
Report No. HEHS-96-53R |
Title
B-259939 December 8, 1995 The Iionorable Nancy L. Kassebaurn Chairman, Corrmittee on Labor and Human Resources United States Senate Dear Madam Chairman: The Congress, industry groups, and others have raised concerns about delays in the Food and Drug Administration's (FDA) approval of new medical device, pharmaceutical, and biologic products. In the last 5 years, the Congress provided additional fu... |
| Date Oct. 30, 1995 |
Report No. PEMD-96-2 |
Title
United States General Accounting Office GAO
October 1995 Report to the Chairman, Subcommittee on Oversight and Investigations, Committee on Commerce, House of Representatives MEDICAL DEVICES FDA Review Time GAO/PEMD-96-2 GAO United States General Accounting Office Washington, D.C. 20548 Program Evaluation and Methodology Division B-261822 October 30, 1995 The Honorable Joe Barton Chairman, Subcomm... |
| Date Oct. 26, 1995 |
Report No. AIMD/RCED-96-21R |
Title
GAO States GeneralAccounting Office Washington, D.C.20548
United B-266002 October 26, 1995 The Honorable Pat Roberts Chairman The Honorable E. Kika de la Garza Ranking Minority Member Committee on Agriculture House of Representatives As agreed with your offices, this letter provides suggested amendments to H.R. 1627, the Food Quality Protection Act of 1995, that would improve the Environmental Pro... |
| Date Oct. 20, 1995 |
Report No. PEMD-96-1 |
Title
United States General Accounting Office GAO
October 1995 Report to Congressional Requesters FDA DRUG APPROVAL Review Time Has Decreased in Recent Years GAO/PEMD-96-1 GAO United States General Accounting Office Washington, D.C. 20548 Program Evaluation and Methodology Division B-266023 October 20, 1995 The Honorable Nancy Landon Kassebaum Chairman The Honorable Edward M. Kennedy Ranking Minority Me... |
| Date June 30, 1995 |
Report No. RCED-95-228 |
Title
United States General Accounting Office Report to Congressional Requesters MEAT AND POULTRY .INsPECnoN Impact of USDKs Food ’ Safety Proposal on State Agencies and Small Plants GAO/RCED-95-228 United States General Accounting Office Washington, D.C. 20548 Resources, Community, Economic Development and Division B-261674 June 30,1995 The Honorable Pat Roberts Chairman The Honorable E (Kika) de la ... |
| Date Jan. 18, 1995 |
Report No. GGD-95-52R |
Title
GAO United States General Accounting Offke Washington, D.C. 20548 General Government Division B-259550 January 18, 1995 Jr. The Honorable F. James Sensenbrenner, House of Representatives Dear Mr. Sensenbrenner: This correspondence responds to your request for information on how certain controlled substances are regulated, particularly methylphenidate-a central nervous system stimulant approved for... |
| Date Dec. 29, 1994 |
Report No. RCED-95-19 |
Title
;A0 t' . United States General Accountinq Distribution for Restricted GAO Reports (Form 115-R)
-----,__----------------------------------------======-------- Office ----e--m _______-__ ----_-__-_-___________c_________________---- must approve distribution of Restricted Reports. This report is restricted for 7 days. OCR Approval Report Number and GAOIRCED-95-19 Date I Classified: (Check one, if ap... |
| Date Sept. 26, 1994 |
Report No. RCED-94-192 |
Title
United States General Accounting Office u-$4 w GAO
September 1994 Report to the Chairman, Human Resources and Intergovernmental Relations Subcomm%tee, Committee on Government Operations, House of Representatives FOOD SAFETY Changes Needed to Minimize Unsafe Chemicals in Food
I GAO/RCED-94-192 1 I j I , 1 Notice: This is a reprint of a GAO report.
f Resources, Community, and Economic Development Di... |
| Date May 25, 1994 |
Report No. T-RCED-94-223 |
Title
United States General Accounting Office GAO
For Releaseon Delivery Expectedat 9:30 am. EDT Wednesday hky 2% 1994 Testimony
Before the Human Resourcesand Intergovernmental Relations Subcommittee, Committee on Government Operations, House of Representatives FOOD SAFETY A Unified, Risk-Based Food Safety System Needed
Statement of John W. Harman, Director, Food and Agriculture Issues, Resources,Commun... |
| Date May 13, 1994 |
Report No. RCED-94-57 |
Title
United States General Accounting Office GAO
May 1994 Report to Congressional Committees PESTICIDES Options to Achieve a Single Regulatory Standard .
GAWRCED-94-57 GAO United States General Accounting Office Washington, D.C. 20548 Resources, Community, Economic Development B-255441 and Division May 13,1994 Congressional Committees Different standards in the two key federal pesticide laws-the Federa... |
| Date May 6, 1994 |
Report No. HEHS-94-136R |
Title
w-8 Y GAO Washington,D.C.20548
Human Resources Division United States General Accounting Office 1 B-256121 May 6, 1994 The Honorable John D. Dingell Chairman, Committee on Energy House of Representatives The Honorable United States Orrin G. Hatch Senate and Commerce Because of changes over the last few years in the Food and Drug Administration's (FDA) monitoring of generic drug manufacturers,l you... |
| Date Nov. 4, 1993 |
Report No. T-RCED-94-71 |
Title
United States General Accounting Office 3AO Testimony
Before the Human Resourcesand Intergovernmental Relations Subcommittee, Committee on Goveriiment Operations, House of Representatives )r Release on Delivery qected at 30a.m. EST wrsday uvember 4, 1993 FOOD SAFETY A Unified, Risk-Based System Needed to Enhance Food Safety
Statement of John W. Hannan, Director, Food and Agriculture Issues, Resour... |
| Date July 26, 1993 |
Report No. RCED-93-142 |
Title
.llil,r 19’):~ *1 FOOD SAFETY AND QUALITY Innovative Strategies May Be Needed to Regulate New Food Teehnologies
--_._., I 11111 II
149872 RESTRICTED--Not to be released outside the General Accounting Office unless specifically approved by the Office of Congressional Relations. 559657 RELEASED GAO United States General Accounting Of’fice Washingtoxn, D.C. 20648 Resources, Community, and Economi... |
| Date July 1, 1993 |
Report No. GGD-93-82 |
Title
United States General Accounting Office GAO
July 1993 Report to the Chairman, Committee on Government Operations, House of Representatives CONFRONT1 DRUG PROBL THE Debate Persists on Enforcement proaches Alternative GAO United States General Accounting OfYice Washington, D.C. 20648 General Government Division B-252934 July 1,1993 The Honorable John Conyers, Jr. Chairman, Committee on Government Op... |
